Research analysts at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a report released on Tuesday. The firm set a “buy” rating on the stock.
Mannatech Price Performance
Mannatech stock opened at $12.33 on Tuesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74. The business has a 50 day simple moving average of $11.30 and a 200-day simple moving average of $8.84. Mannatech has a 12 month low of $6.75 and a 12 month high of $15.83. The stock has a market capitalization of $23.18 million, a PE ratio of -15.22 and a beta of 1.04.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The firm had revenue of $31.73 million for the quarter.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Articles
- Five stocks we like better than Mannatech
- 3 Dividend Kings To Consider
- Oracle Announces Game-Changing News for the AI Industry
- About the Markup Calculator
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Stock Average Calculator
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
